https://blog.billiondollarblindspot.com/p/gilead-tubulis-european-biotech-exit-ovarian-cancer-capital-signalThe Billion Dollar Blindspoten2026-04-08T22:30:18+00:00Gilead Just Paid $5 Billion for a European Biotech. The Indication Was Ovarian Cancer. That's Not a Coincidence.